Live from the NIH registry
Studies recruiting near Pittsburgh right now
Top 25 of 1,232 recruiting studies, sorted by proximity — each links to its official registry page
Extracorporeal Photopheresis in Sezary Syndrome
Sezary Syndrome
N/A
Observational 20 participants sought
University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: Oleg E. Akilov, MD, PhD
Pupil-Indexed Noninvasive Neuromodulation
Paresis
N/A
Interventional 110 participants sought
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: VA Office of Research and Development
A Non-interventional, International, Multicentre Clinical Research Study to Build the Largest Collection of Multimodal Data (Including Clinical Data, Imaging Data and Omics Data) in Oncology
Diffuse Large B Cell Lymphoma, Solid Tumor Cancer
N/A
Observational 7,000 participants sought
University of Pittsburgh — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: OWKIN
Assessing Improvements in Mood and Sleep Trial
Depression, Suicidality
N/A
Interventional 420 participants sought
University of Pittsburgh — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: University of Pittsburgh
BioHealx® Anal Fistula Device Post Market Surveillance Study
Fistula-in-ano
N/A
Observational 50 participants sought
Maininle Health Lankenau — Bryn Mawr, Pennsylvania (11.0 mi)
· Sponsor: Signum Surgical USA Inc.
Expiratory Muscle Strength Training for Hypernasal Speech in Children
Velopharyngeal Insufficiency, Velopharyngeal Incompetence Due to Cleft Palate
N/A
Interventional 30 participants sought
UPMC Children's Hospital of Pittsburgh — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: Noel Jabbour
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital of Pittsburgh of UPMC — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
Thrombocythemia, Essential, Primary Myelofibrosis
Phase 3
Interventional 400 participants sought
UPMC Hillman Cancer Center ( Site 6004) — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: Sameek Roychowdhury
Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems
Peripheral Neuropathies, Peripheral Neuropathy Due to Chemotherapy
N/A
Interventional 200 participants sought
University of Pittsburgh — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: RxFunction Inc.
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Monroeville, Pennsylvania (10.0 mi)
· Sponsor: Daiichi Sankyo
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
UPMC-Saint Margaret — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Allegheny General Hospital — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
Allegheny Health Network — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: University of Alabama at Birmingham
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: AstraZeneca
Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Pediatric and Adults Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)
Medium-chain Acyl-CoA Dehydrogenase Deficiency
Phase 2
Interventional 24 participants sought
UPMC Children's Hospital of Pittsburgh — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: Jerry Vockley, MD, PhD
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
Colo-rectal Cancer
Phase 2
Interventional 79 participants sought
Allegheny General Hospital — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: NSABP Foundation Inc
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection Recurrence
Phase 2
Interventional 20 participants sought
Romano, Pontzer & Associated — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: Acurx Pharmaceuticals Inc.
Nicotinamide Riboside in Ulcerative Colitis
Ulcerative Colitis
N/A
Interventional 40 participants sought
UPMC Children's Hospital of Pittsburgh — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: University of Pittsburgh
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Phase 3
Interventional 428 participants sought
Bryn Mawr Hospital — Bryn Mawr, Pennsylvania (11.0 mi)
· Sponsor: NRG Oncology
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: AstraZeneca
A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
Chronic Graft-versus-host-disease
Phase 2
Interventional 60 participants sought
Childrens Hospital of Pittsburgh — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: Incyte Corporation
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
AHN Allegheny General Hospital — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: Eli Lilly and Company
Safety And Tolerability Of Gamma Glutamylcysteine (GGC) Oral Supplementation In MCI Patients
Mild Cognitive Impairment (MCI)
Phase 1
Interventional 9 participants sought
UPMC Presbyterian Hospital — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: Pravat Mandal
Dorothy P. and Richard P. Simmons Center for ILD Research Registry
Lung Diseases, Interstitial
N/A
Observational 5,000 participants sought
Michelle F MacPherson — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: University of Pittsburgh